生命科学资讯

Stryker promotes new president, COO to help lead its M&A strategy

Mirum beckons Bluejay and its phase 3-stage hepatitis drug for $620M

Wave, Structure stocks double on obesity data readouts

Dyne readies FDA push after DMD exon 51 med excels in trial

Dr. Reddy's pens $370M pact for rights to Immutep's phase 3-stage immunotherapy in certain markets

Cogent’s mastocytosis drug continues momentum, helps treat sicker patients

Day One was one of three parties interested in Mersana; Bihua Chen and Cormorant’s third SPAC

#ASH25: Kura, Syndax detail data for rival menin inhibitors as both eye earlier use in AML

Dyne to seek Duchenne drug approval; Kymera, Wave and Structure shares soar

ASH 2025: Speeding AML research with MRD surrogate endpoint

Med-tech gainers and losers for Dec. 1-5, 2025

Biggest gainers and losers for Dec. 1-5, 2025

Precision oncology at your community’s doorstep - Illumina

Merck outbid three competitors in Cidara acquisition — new filing

Structure Therapeutics’ obesity pill stacks up with Novo and Lilly; Ascletis also reports early results

Structures of G-protein coupled receptor HCAR3 in complex with selective agonists reveal the basis for ligand recognition and selectivity

Prolonged starvation deepens quiescence in Vasa2/Piwi1-expressing cells of a sea anemone

From pipeline to network: We need to redefine scientific success

The deubiquitinating enzyme Cezanne stabilizes BRCA1 by counteracting APC/C and Ube2S-dependent Lys11-linked ubiquitination

A new path to spillover: MHC-II entry of influenza A viruses